產(chǎn)品詳情
簡單介紹:
GFT505
詳情介紹:
Characteristics |
PubChem CID: 9864881 Salt form: No GFT505 (Elafibranor) is a novel liver-targeted peroxisome proliferator-activated receptor alpha/delta (PPARα/δ) agonist. Displays anti-diabetic effects in db/db mice. Smiles: CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC InChi: InChI=1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+ Inchi Key: AFLFKFHDSCQHOL-IZZDOVSWSA-N |
Purity | ≥ 98?% by HPLC |
Chemical Name | 2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid; Elafibranor |
Formula | C??H??O?S |
Permeability | Cell-permeable |
Background | Synonyms: 2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid, Elafibranor |
Molecular Weight | 384.39 g/mol |
CAS-No | 923978-27-2 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from air and light |
Storage | -20 °C |
Expiry Date | 36 months |